Copyright Reports & Markets. All rights reserved.

Global Polycystic Ovary Syndrome (PCOS) Drugs Market Research Report 2019

Buy now

Table of Contents

    Executive Summary

      1 Polycystic Ovary Syndrome (PCOS) Drugs Market Overview

      • 1.1 Product Overview and Scope of Polycystic Ovary Syndrome (PCOS) Drugs
      • 1.2 Polycystic Ovary Syndrome (PCOS) Drugs Segment by Type
        • 1.2.1 Global Polycystic Ovary Syndrome (PCOS) Drugs Production Growth Rate Comparison by Type (2014-2025)
        • 1.2.2 Oral Contraceptives
        • 1.2.3 Antiandrogens
        • 1.2.4 Insulin-sensitizing Agent
        • 1.2.5 Antidepressant
        • 1.2.6 Anti-obesity
      • 1.3 Polycystic Ovary Syndrome (PCOS) Drugs Segment by Application
        • 1.3.1 Polycystic Ovary Syndrome (PCOS) Drugs Consumption Comparison by Application (2014-2025)
        • 1.3.2 Hospital
        • 1.3.3 Clinic
      • 1.3 Global Polycystic Ovary Syndrome (PCOS) Drugs Market by Region
        • 1.3.1 Global Polycystic Ovary Syndrome (PCOS) Drugs Market Size Region
        • 1.3.2 North America Status and Prospect (2014-2025)
        • 1.3.3 Europe Status and Prospect (2014-2025)
        • 1.3.4 China Status and Prospect (2014-2025)
        • 1.3.5 Japan Status and Prospect (2014-2025)
        • 1.3.6 Southeast Asia Status and Prospect (2014-2025)
        • 1.3.7 India Status and Prospect (2014-2025)
      • 1.4 Global Polycystic Ovary Syndrome (PCOS) Drugs Market Size
        • 1.4.1 Global Polycystic Ovary Syndrome (PCOS) Drugs Revenue (2014-2025)
        • 1.4.2 Global Polycystic Ovary Syndrome (PCOS) Drugs Production (2014-2025)

      2 Global Polycystic Ovary Syndrome (PCOS) Drugs Market Competition by Manufacturers

      • 2.1 Global Polycystic Ovary Syndrome (PCOS) Drugs Production Market Share by Manufacturers (2014-2019)
      • 2.2 Global Polycystic Ovary Syndrome (PCOS) Drugs Revenue Share by Manufacturers (2014-2019)
      • 2.3 Global Polycystic Ovary Syndrome (PCOS) Drugs Average Price by Manufacturers (2014-2019)
      • 2.4 Manufacturers Polycystic Ovary Syndrome (PCOS) Drugs Production Sites, Area Served, Product Types
      • 2.5 Polycystic Ovary Syndrome (PCOS) Drugs Market Competitive Situation and Trends
        • 2.5.1 Polycystic Ovary Syndrome (PCOS) Drugs Market Concentration Rate
        • 2.5.2 Polycystic Ovary Syndrome (PCOS) Drugs Market Share of Top 3 and Top 5 Manufacturers
        • 2.5.3 Mergers & Acquisitions, Expansion

      3 Global Polycystic Ovary Syndrome (PCOS) Drugs Production Market Share by Regions

      • 3.1 Global Polycystic Ovary Syndrome (PCOS) Drugs Production Market Share by Regions
      • 3.2 Global Polycystic Ovary Syndrome (PCOS) Drugs Revenue Market Share by Regions (2014-2019)
      • 3.3 Global Polycystic Ovary Syndrome (PCOS) Drugs Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.4 North America Polycystic Ovary Syndrome (PCOS) Drugs Production
        • 3.4.1 North America Polycystic Ovary Syndrome (PCOS) Drugs Production Growth Rate (2014-2019)
        • 3.4.2 North America Polycystic Ovary Syndrome (PCOS) Drugs Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.5 Europe Polycystic Ovary Syndrome (PCOS) Drugs Production
        • 3.5.1 Europe Polycystic Ovary Syndrome (PCOS) Drugs Production Growth Rate (2014-2019)
        • 3.5.2 Europe Polycystic Ovary Syndrome (PCOS) Drugs Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.6 China Polycystic Ovary Syndrome (PCOS) Drugs Production (2014-2019)
        • 3.6.1 China Polycystic Ovary Syndrome (PCOS) Drugs Production Growth Rate (2014-2019)
        • 3.6.2 China Polycystic Ovary Syndrome (PCOS) Drugs Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.7 Japan Polycystic Ovary Syndrome (PCOS) Drugs Production (2014-2019)
        • 3.7.1 Japan Polycystic Ovary Syndrome (PCOS) Drugs Production Growth Rate (2014-2019)
        • 3.7.2 Japan Polycystic Ovary Syndrome (PCOS) Drugs Production, Revenue, Price and Gross Margin (2014-2019)

      4 Global Polycystic Ovary Syndrome (PCOS) Drugs Consumption by Regions

      • 4.1 Global Polycystic Ovary Syndrome (PCOS) Drugs Consumption by Regions
      • 4.2 North America Polycystic Ovary Syndrome (PCOS) Drugs Consumption (2014-2019)
      • 4.3 Europe Polycystic Ovary Syndrome (PCOS) Drugs Consumption (2014-2019)
      • 4.4 China Polycystic Ovary Syndrome (PCOS) Drugs Consumption (2014-2019)
      • 4.5 Japan Polycystic Ovary Syndrome (PCOS) Drugs Consumption (2014-2019)

      5 Global Polycystic Ovary Syndrome (PCOS) Drugs Production, Revenue, Price Trend by Type

      • 5.1 Global Polycystic Ovary Syndrome (PCOS) Drugs Production Market Share by Type (2014-2019)
      • 5.2 Global Polycystic Ovary Syndrome (PCOS) Drugs Revenue Market Share by Type (2014-2019)
      • 5.3 Global Polycystic Ovary Syndrome (PCOS) Drugs Price by Type (2014-2019)
      • 5.4 Global Polycystic Ovary Syndrome (PCOS) Drugs Production Growth by Type (2014-2019)

      6 Global Polycystic Ovary Syndrome (PCOS) Drugs Market Analysis by Applications

      • 6.1 Global Polycystic Ovary Syndrome (PCOS) Drugs Consumption Market Share by Application (2014-2019)
      • 6.2 Global Polycystic Ovary Syndrome (PCOS) Drugs Consumption Growth Rate by Application (2014-2019)

      7 Company Profiles and Key Figures in Polycystic Ovary Syndrome (PCOS) Drugs Business

      • 7.1 Sanofi
        • 7.1.1 Sanofi Polycystic Ovary Syndrome (PCOS) Drugs Production Sites and Area Served
        • 7.1.2 Polycystic Ovary Syndrome (PCOS) Drugs Product Introduction, Application and Specification
        • 7.1.3 Sanofi Polycystic Ovary Syndrome (PCOS) Drugs Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.1.4 Main Business and Markets Served
      • 7.2 Novartis AG
        • 7.2.1 Novartis AG Polycystic Ovary Syndrome (PCOS) Drugs Production Sites and Area Served
        • 7.2.2 Polycystic Ovary Syndrome (PCOS) Drugs Product Introduction, Application and Specification
        • 7.2.3 Novartis AG Polycystic Ovary Syndrome (PCOS) Drugs Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.2.4 Main Business and Markets Served
      • 7.3 Teva Pharmaceutical Industries Limited
        • 7.3.1 Teva Pharmaceutical Industries Limited Polycystic Ovary Syndrome (PCOS) Drugs Production Sites and Area Served
        • 7.3.2 Polycystic Ovary Syndrome (PCOS) Drugs Product Introduction, Application and Specification
        • 7.3.3 Teva Pharmaceutical Industries Limited Polycystic Ovary Syndrome (PCOS) Drugs Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.3.4 Main Business and Markets Served
      • 7.4 Addex Therapeutics Ltd.
        • 7.4.1 Addex Therapeutics Ltd. Polycystic Ovary Syndrome (PCOS) Drugs Production Sites and Area Served
        • 7.4.2 Polycystic Ovary Syndrome (PCOS) Drugs Product Introduction, Application and Specification
        • 7.4.3 Addex Therapeutics Ltd. Polycystic Ovary Syndrome (PCOS) Drugs Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.4.4 Main Business and Markets Served
      • 7.5 BIOCAD
        • 7.5.1 BIOCAD Polycystic Ovary Syndrome (PCOS) Drugs Production Sites and Area Served
        • 7.5.2 Polycystic Ovary Syndrome (PCOS) Drugs Product Introduction, Application and Specification
        • 7.5.3 BIOCAD Polycystic Ovary Syndrome (PCOS) Drugs Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.5.4 Main Business and Markets Served
      • 7.6 Merck KGaA
        • 7.6.1 Merck KGaA Polycystic Ovary Syndrome (PCOS) Drugs Production Sites and Area Served
        • 7.6.2 Polycystic Ovary Syndrome (PCOS) Drugs Product Introduction, Application and Specification
        • 7.6.3 Merck KGaA Polycystic Ovary Syndrome (PCOS) Drugs Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.6.4 Main Business and Markets Served
      • 7.7 AstraZeneca plc.
        • 7.7.1 AstraZeneca plc. Polycystic Ovary Syndrome (PCOS) Drugs Production Sites and Area Served
        • 7.7.2 Polycystic Ovary Syndrome (PCOS) Drugs Product Introduction, Application and Specification
        • 7.7.3 AstraZeneca plc. Polycystic Ovary Syndrome (PCOS) Drugs Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.7.4 Main Business and Markets Served
      • 7.8 Bristol Myers Squibb Co.
        • 7.8.1 Bristol Myers Squibb Co. Polycystic Ovary Syndrome (PCOS) Drugs Production Sites and Area Served
        • 7.8.2 Polycystic Ovary Syndrome (PCOS) Drugs Product Introduction, Application and Specification
        • 7.8.3 Bristol Myers Squibb Co. Polycystic Ovary Syndrome (PCOS) Drugs Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.8.4 Main Business and Markets Served
      • 7.9 Ferring Pharmaceuticals, Inc.
        • 7.9.1 Ferring Pharmaceuticals, Inc. Polycystic Ovary Syndrome (PCOS) Drugs Production Sites and Area Served
        • 7.9.2 Polycystic Ovary Syndrome (PCOS) Drugs Product Introduction, Application and Specification
        • 7.9.3 Ferring Pharmaceuticals, Inc. Polycystic Ovary Syndrome (PCOS) Drugs Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.9.4 Main Business and Markets Served
      • 7.10 Crinetics Pharmaceuticals, Inc.
        • 7.10.1 Crinetics Pharmaceuticals, Inc. Polycystic Ovary Syndrome (PCOS) Drugs Production Sites and Area Served
        • 7.10.2 Polycystic Ovary Syndrome (PCOS) Drugs Product Introduction, Application and Specification
        • 7.10.3 Crinetics Pharmaceuticals, Inc. Polycystic Ovary Syndrome (PCOS) Drugs Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.10.4 Main Business and Markets Served

      8 Polycystic Ovary Syndrome (PCOS) Drugs Manufacturing Cost Analysis

      • 8.1 Polycystic Ovary Syndrome (PCOS) Drugs Key Raw Materials Analysis
        • 8.1.1 Key Raw Materials
        • 8.1.2 Price Trend of Key Raw Materials
        • 8.1.3 Key Suppliers of Raw Materials
      • 8.2 Proportion of Manufacturing Cost Structure
      • 8.3 Manufacturing Process Analysis of Polycystic Ovary Syndrome (PCOS) Drugs
      • 8.4 Polycystic Ovary Syndrome (PCOS) Drugs Industrial Chain Analysis

      9 Marketing Channel, Distributors and Customers

      • 9.1 Marketing Channel
        • 9.1.1 Direct Marketing
        • 9.1.2 Indirect Marketing
      • 9.2 Polycystic Ovary Syndrome (PCOS) Drugs Distributors List
      • 9.3 Polycystic Ovary Syndrome (PCOS) Drugs Customers

      10 Market Dynamics

      • 10.1 Market Trends
      • 10.2 Opportunities
      • 10.3 Market Drivers
      • 10.4 Challenges
      • 10.5 Influence Factors

      11 Global Polycystic Ovary Syndrome (PCOS) Drugs Market Forecast

      • 11.1 Global Polycystic Ovary Syndrome (PCOS) Drugs Production, Revenue Forecast
        • 11.1.1 Global Polycystic Ovary Syndrome (PCOS) Drugs Production Growth Rate Forecast (2019-2025)
        • 11.1.2 Global Polycystic Ovary Syndrome (PCOS) Drugs Revenue and Growth Rate Forecast (2019-2025)
        • 11.1.3 Global Polycystic Ovary Syndrome (PCOS) Drugs Price and Trend Forecast (2019-2025)
      • 11.2 Global Polycystic Ovary Syndrome (PCOS) Drugs Production Forecast by Regions (2019-2025)
        • 11.2.1 North America Polycystic Ovary Syndrome (PCOS) Drugs Production, Revenue Forecast (2019-2025)
        • 11.2.2 Europe Polycystic Ovary Syndrome (PCOS) Drugs Production, Revenue Forecast (2019-2025)
        • 11.2.3 China Polycystic Ovary Syndrome (PCOS) Drugs Production, Revenue Forecast (2019-2025)
        • 11.2.4 Japan Polycystic Ovary Syndrome (PCOS) Drugs Production, Revenue Forecast (2019-2025)
      • 11.3 Global Polycystic Ovary Syndrome (PCOS) Drugs Consumption Forecast by Regions (2019-2025)
        • 11.3.1 North America Polycystic Ovary Syndrome (PCOS) Drugs Consumption Forecast (2019-2025)
        • 11.3.2 Europe Polycystic Ovary Syndrome (PCOS) Drugs Consumption Forecast (2019-2025)
        • 11.3.3 China Polycystic Ovary Syndrome (PCOS) Drugs Consumption Forecast (2019-2025)
        • 11.3.4 Japan Polycystic Ovary Syndrome (PCOS) Drugs Consumption Forecast (2019-2025)
      • 11.4 Global Polycystic Ovary Syndrome (PCOS) Drugs Production, Revenue and Price Forecast by Type (2019-2025)
      • 11.5 Global Polycystic Ovary Syndrome (PCOS) Drugs Consumption Forecast by Application (2019-2025)

      12 Research Findings and Conclusion

        13 Methodology and Data Source

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        The global Polycystic Ovary Syndrome (PCOS) Drugs market is valued at million US$ in 2018 is expected to reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
        This report focuses on Polycystic Ovary Syndrome (PCOS) Drugs volume and value at global level, regional level and company level. From a global perspective, this report represents overall Polycystic Ovary Syndrome (PCOS) Drugs market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
        At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

        The following manufacturers are covered:
        Sanofi
        Novartis AG
        Teva Pharmaceutical Industries Limited
        Addex Therapeutics Ltd.
        BIOCAD
        Merck KGaA
        AstraZeneca plc.
        Bristol Myers Squibb Co.
        Ferring Pharmaceuticals, Inc.
        Crinetics Pharmaceuticals, Inc.

        Segment by Regions
        North America
        Europe
        China
        Japan

        Segment by Type
        Oral Contraceptives
        Antiandrogens
        Insulin-sensitizing Agent
        Antidepressant
        Anti-obesity

        Segment by Application
        Hospital
        Clinic

        Buy now